Sg3 Management, LLC Acadia Pharmaceuticals Inc Put Options Transaction History

Sg3 Management, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 15, 2022	SELL	$13.01 - $27.22 $78,060 - $163,320	-6,000 Reduced 8.51%	64,500 $909,000
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $1.48 Million - $1.94 Million	70,500 New	70,500 $1.71 Million
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $1.77 Million - $2.5 Million	-91,100 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $2.28 Million - $5.01 Million	91,100 New	91,100 $2.35 Million

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.